The objective of the present study was to develop and validated analytical method for the determination of Ezetimibe in bulk and The value of correlation coefficient was found to be 0.999. Method was found good percentage recovery it indicate the method is highly accurate. The method has been successfully applied for determination of Ezetimibe in pharmaceutical dosage form in regular quality control analysis.
Ezetimibe is widely used in treatment of hypercholesterolemia and of sitosterolemia. [1] Ezetimibe chemical name is
1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-
hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone4. Literature survey reveals that UV [2] [3] [4] , HPLC [5] [6] [7] and LC-MS [8] [9] methods reported for Ezetimibe. The aim of present work was to develop and validate a novel, rapid, simple, precise, sensitive and specific RP-HPLC method for the determination of Ezetimibe in its bulk and pharmaceutical formulations. 
Preparation of standard solution
A standard stock solution of the drug was prepared by dissolving 100 mg of Ezetimibe volumetric flask containing 40 ml mobile phase, then sonicated for about 10 minutes and made up to 100 ml with mobile phase to get the primary standard stock solution containing 1000 μg/ml Ezetimibe.Working standard solutions were prepared by further dilution with mobile phase.
Preparation of sample solution
20 tablets of local brand (Ezetimibe) were randomly selected and crushed them to a fine powder a quantity of 0.138 g of tablet powder equivalent to 500 mg of Ezetimibe was transferred to 100 mL volumetric flask and dissolved in diluent and the volume was adjusted up to the mark with diluent. The mixture was allowed to stand for 10 min with intermittent sonication to ensure complete dissolution. The resulting solution was filtered through a 0.22 μm membrane filter. The filtrate was diluted further with mobile phase to get the working sample solution.
RESULTS AND DISCUSSION

Method development and optimization
Initially method development was started with the selection of wavelength of detection. The UV spectrum of Ezetimibe in mobile phase was noted using UV spectrophotometer. The maximum absorbance was noticed at 230 nm. This wavelength was used for detection of Ezetimibe.
Validation of the method
The proposed method was developed by several concurrent trails in order to establish the preferred chromatographic conditions which would be helpful to conduct a complete validation study. Details of the method optimization was shown in Table 1 The specificity was studied for the examination of the presence of interfering components, while the comparison of chromatograms there was no interference observed. The chromatographic results for the calibration standards are presented in Table 2 . The calibration curve for Ezetimibe was found to be linear over the range of 20-70 μg/mL. The regression equation for Ezetimibe was found to be Y=186.54x-295.13 with correlation coefficient, R2=0.999, which indicates this method has good linearity. The data of the regression analysis of the calibration results is shown in Table 2 and linearity plot of Ezetimibe shown in Figure   4 . Precision was studied to find out intra-day and inter-day variation in the test methods of Ezetimibe for 6 times on the same day and different days. The intra-day and inter-day precision obtained was % RSD (<2.0) indicates that the proposed method is quite precise and reproducible and results are shown in Table 3 and Table 4 . Recovery studies of the drug were carried out for the accuracy parameters at three different concentration levels that are multiple level recovery studies. A known amount standard was added into pre analyzed sample and subjected them to proposed HPLC method. The % recovery was found to be within the limits as listed in Table 5 . The mean percentage recovery of Ezetimibe at each level was not less than 98% and not more than 102%. Robustness was done by small changes in chromatographic conditions like flow rate and detection of wave length etc. It was observed that there were no marked changes in chromatograms. In fact the parameters are within the limits which indicates that the method has robustness and suitable for routine use.
The robustness results are shown in Table 6 . Method validation following ICH guidelines indicated that the developed method had high sensitivity with 0.03 μg/mL and 0.09 μg/mL was shown in Table 7 . 
